Paul B. Yu

Paul Yu, Ph.D., M.D.

Associate Professor of Medicine, Brigham and Women's Hospital
857-307-0390
Publications View
NEDD9 targets COL3A1 to promote endothelial fibrosis and pulmonary arterial hypertension.
Authors: Authors: Samokhin AO, Stephens T, Wertheim BM, Wang RS, Vargas SO, Yung LM, Cao M, Brown M, Arons E, Dieffenbach PB, Fewell JG, Matar M, Bowman FP, Haley KJ, Alba GA, Marino SM, Kumar R, Rosas IO, Waxman AB, Oldham WM, Khanna D, Graham BB, Seo S, Gladyshev VN, Yu PB, Fredenburgh LE, Loscalzo J, Leopold JA, Maron BA.
Sci Transl Med
View full abstract on Pubmed
Career Development of Young Physician-Scientists in the Cardiovascular Sciences: Perspective and Advice From the Early Career Committee of the Cardiopulmonary, Critical Care, and Resuscitation Council of the American Heart Association.
Authors: Authors: Agarwal S, Spiekerkoetter E, Austin ED, de Jesus Perez V, Dezfulian C, Maron BA, Ryan JJ, Starks MA, Yu PB, Bonnet S, Perman SM.
Circ Res
View full abstract on Pubmed
The obligatory role of Activin A in the formation of heterotopic bone in Fibrodysplasia Ossificans Progressiva.
Authors: Authors: Alessi Wolken DM, Idone V, Hatsell SJ, Yu PB, Economides AN.
Bone
View full abstract on Pubmed
Correction for Bagarova et al., "Constitutively Active ALK2 Receptor Mutants Require Type II Receptor Cooperation".
Authors: Authors: Bagarova J, Vonner AJ, Armstrong KA, Börgermann J, Lai CSC, Deng DY, Beppu H, Alfano I, Filippakopoulos P, Morrell NW, Bullock AN, Knaus P, Mishina Y, Yu PB.
Mol Cell Biol
View full abstract on Pubmed
Strategic Targeting of Multiple BMP Receptors Prevents Trauma-Induced Heterotopic Ossification.
Authors: Authors: Agarwal S, Loder SJ, Breuler C, Li J, Cholok D, Brownley C, Peterson J, Hsieh HH, Drake J, Ranganathan K, Niknafs YS, Xiao W, Li S, Kumar R, Tompkins R, Longaker MT, Davis TA, Yu PB, Mishina Y, Levi B.
Mol Ther
View full abstract on Pubmed
The traumatic bone: trauma-induced heterotopic ossification.
Authors: Authors: Dey D, Wheatley BM, Cholok D, Agarwal S, Yu PB, Levi B, Davis TA.
Transl Res
View full abstract on Pubmed
Macrophage migration inhibitory factor as a novel biomarker of portopulmonary hypertension.
Authors: Authors: DuBrock HM, Rodriguez-Lopez JM, LeVarge BL, Curry MP, VanderLaan PA, Zsengeller ZK, Pernicone E, Preston IR, Yu PB, Nikolic I, Xu D, Thadhani RI, Channick RN, Ananth Karumanchi S.
Pulm Circ
View full abstract on Pubmed
Two tissue-resident progenitor lineages drive distinct phenotypes of heterotopic ossification.
Authors: Authors: Dey D, Bagarova J, Hatsell SJ, Armstrong KA, Huang L, Ermann J, Vonner AJ, Shen Y, Mohedas AH, Lee A, Eekhoff EM, van Schie A, Demay MB, Keller C, Wagers AJ, Economides AN, Yu PB.
Sci Transl Med
View full abstract on Pubmed
A Selective Transforming Growth Factor-ß Ligand Trap Attenuates Pulmonary Hypertension.
Authors: Authors: Yung LM, Nikolic I, Paskin-Flerlage SD, Pearsall RS, Kumar R, Yu PB.
Am J Respir Crit Care Med
View full abstract on Pubmed
Up-regulation of the mammalian target of rapamycin complex 1 subunit Raptor by aldosterone induces abnormal pulmonary artery smooth muscle cell survival patterns to promote pulmonary arterial hypertension.
Authors: Authors: Aghamohammadzadeh R, Zhang YY, Stephens TE, Arons E, Zaman P, Polach KJ, Matar M, Yung LM, Yu PB, Bowman FP, Opotowsky AR, Waxman AB, Loscalzo J, Leopold JA, Maron BA.
FASEB J
View full abstract on Pubmed